Zhao, Jimmy L.
Antonarakis, Emmanuel S.
Cheng, Heather H.
George, Daniel J. http://orcid.org/0000-0002-0836-8542
Aggarwal, Rahul http://orcid.org/0000-0001-7003-7982
Riedel, Elyn
Sumiyoshi, Takayuki
Schonhoft, Joseph D.
Anderson, Amanda
Mao, Ninghui
Haywood, Samuel
Decker, Brooke
Curley, Tracy
Abida, Wassim
Feng, Felix Y.
Knudsen, Karen
Carver, Brett
Lacouture, Mario E.
Wyatt, Alexander W. http://orcid.org/0000-0003-2399-0329
Rathkopf, Dana http://orcid.org/0000-0002-4503-7582
Funding for this research was provided by:
Celgene
Bristol-Myers Squibb Company | Bristol-Myers Squibb Canada
Gateway for Cancer Research
JLZ was supported by a K12 Paul Calabresi Career Development Award for Clinical Oncology and a Prostate Cancer Foundation Young Investigator Award.
Article History
Received: 16 March 2023
Revised: 13 October 2023
Accepted: 30 October 2023
First Online: 18 November 2023
Competing interests
: JLZ is currently a full-time employee at AstraZeneca, which is not involved in the funding and conduct of the trial. The authors declare no competing interests.
: IRB committee approval was obtained from all participating sites and written consent was obtained by all participating patients. The study was performed in accordance with the Declaration of Helsinki.